|
TCOF1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.63002944475465E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.06730213345463E-11 |
| Normal-vs-Stage2 |
2.497300E-03 |
| Normal-vs-Stage3 |
2.38409999997469E-06 |
| Normal-vs-Stage4 |
6.407300E-04 |
| Stage1-vs-Stage2 |
7.850800E-01 |
| Stage1-vs-Stage3 |
2.876500E-02 |
| Stage1-vs-Stage4 |
4.269700E-02 |
| Stage2-vs-Stage3 |
1.040960E-01 |
| Stage2-vs-Stage4 |
6.387600E-02 |
| Stage3-vs-Stage4 |
6.761600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.94129173741931E-14 |
| Normal-vs-AfricanAmerican |
1.98159999520442E-08 |
| Normal-vs-Asian |
6.632000E-02 |
| Caucasian-vs-AfricanAmerican |
4.193600E-01 |
| Caucasian-vs-Asian |
2.844400E-01 |
| AfricanAmerican-vs-Asian |
3.753000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.91897625462434E-12 |
| Normal-vs-Female |
3.19744231092045E-14 |
| Male-vs-Female |
5.152000E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.57455999999501E-05 |
| Normal-vs-Extreme_Weight |
1.99649996535101E-09 |
| Normal-vs-Obese |
2.32659447263472E-11 |
| Normal-vs-Extreme_Obese |
2.222400E-01 |
| Normal_Weight-vs-Extreme_Weight |
8.768400E-01 |
| Normal_Weight-vs-Obese |
1.181990E-01 |
| Normal_Weight-vs-Extreme_Obese |
1.523230E-01 |
| Extreme_Weight-vs-Obese |
8.621800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
1.013640E-01 |
| Obese-vs-Extreme_Obese |
1.836070E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.76639999999973E-05 |
| Normal-vs-Age(41-60Yrs) |
1.62558855265615E-12 |
| Normal-vs-Age(61-80Yrs) |
4.78380002277845E-10 |
| Normal-vs-Age(81-100Yrs) |
9.640200E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.188030E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.137600E-03 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.303790E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.480600E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.506000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.211400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.62836411021772E-12 |
| Normal-VS-Type2 PRCC |
1.97701999999911E-05 |
| Normal-VS-KIRP CIMP |
3.037100E-04 |
| Normal-VS-Unclassified PRCC |
4.78010000004581E-06 |
| Type1 PRCC-VS-Type2 PRCC |
7.469600E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.230500E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.737600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.484100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
9.970000E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.326400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.64179999999825E-05 |
| Normal-vs-N1 |
1.17629999996094E-06 |
| Normal-vs-N2 |
1.55479999985886E-08 |
| N0-vs-N1 |
8.641600E-04 |
| N0-vs-N2 |
1.386410E-02 |
| N1-vs-N2 |
6.169000E-01 |
|
|
